RTO — Rentokil Initial Income Statement
0.000.00%
- $12.13bn
- $16.46bn
- $6.94bn
- 87
- 54
- 57
- 73
Annual income statement for Rentokil Initial, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
Revenue | |||||
Total Revenue | 3,594 | 4,066 | 4,576 | 6,682 | 6,945 |
Cost of Revenue | |||||
Gross Profit | 2,846 | 3,260 | 3,708 | 5,563 | 5,825 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,218 | 3,589 | 4,185 | 5,905 | 6,244 |
Operating Profit | 377 | 476 | 391 | 777 | 701 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 295 | 447 | 365 | 613 | 517 |
Provision for Income Taxes | |||||
Net Income After Taxes | 239 | 362 | 286 | 474 | 392 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 238 | 362 | 286 | 474 | 392 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 238 | 362 | 286 | 474 | 392 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.153 | 0.22 | 0.281 | 0.273 | 0.257 |
Dividends per Share |